Back to Search Start Over

Bitterness prediction of H1-antihistamines and prediction of masking effects of artificial sweeteners using an electronic tongue

Authors :
Ito, Masanori
Ikehama, Kiyoharu
Yoshida, Koichi
Haraguchi, Tamami
Yoshida, Miyako
Wada, Koichi
Uchida, Takahiro
Source :
International Journal of Pharmaceutics. Jan2013, Vol. 441 Issue 1/2, p121-127. 7p.
Publication Year :
2013

Abstract

Abstract: The study objective was to quantitatively predict a drug''s bitterness and estimate bitterness masking efficiency using an electronic tongue (e-Tongue). To verify the predicted bitterness by e-Tongue, actual bitterness scores were determined by human sensory testing. In the first study, bitterness intensities of eight H1-antihistamines were assessed by comparing the Euclidean distances between the drug and water. The distances seemed not to represent the drug''s bitterness, but to be greatly affected by acidic taste. Two sensors were ultimately selected as best suited to bitterness evaluation, and the data obtained from the two sensors depicted the actual taste map of the eight drugs. A bitterness prediction model was established with actual bitterness scores from human sensory testing. Concerning basic bitter substances, such as H1-antihistamines, the predictability of bitterness intensity using e-Tongue was considered to be sufficiently promising. In another study, the bitterness masking efficiency when adding an artificial sweetener was estimated using e-Tongue. Epinastine hydrochloride aqueous solutions containing different levels of acesulfame potassium and aspartame were well discriminated by e-Tongue. The bitterness masking efficiency of epinastine hydrochloride with acesulfame potassium was successfully predicted using e-Tongue by several prediction models employed in the study. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
03785173
Volume :
441
Issue :
1/2
Database :
Academic Search Index
Journal :
International Journal of Pharmaceutics
Publication Type :
Academic Journal
Accession number :
85154062
Full Text :
https://doi.org/10.1016/j.ijpharm.2012.11.047